White Pine Capital LLC Aspira Women'S Health Inc. Transaction History

White Pine Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.4 - $1.09 $34,925 - $95,171	-87,313 Reduced 41.12%	125,000 $73,000
Q1 2022 May 12, 2022	BUY	$0.88 - $1.81 $19,149 - $39,387	21,761 Added 11.42%	212,313 $221,000
Q4 2021 Feb 11, 2022	BUY	$1.63 - $3.43 $266,589 - $560,983	163,552 Added 605.75%	190,552 $337,000
Q3 2021 Nov 10, 2021	BUY	$3.19 - $5.48 $38,280 - $65,760	12,000 Added 80.0%	27,000 $88,000
Q2 2021 Aug 12, 2021	BUY	$4.78 - $6.84 $71,700 - $102,600	15,000 New	15,000 $67,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of White Pine Capital LLC, based on Form 13F filings with the SEC.

Stay updated on White Pine Capital LLC with notifications on news.